Clinical Trial Update: Bardoxolone Methyl Evaluation in Patients With Pulmonary Hypertension (PH) - LARIAT [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial (LARIAT) evaluating Bardoxolone Methyl in patients with pulmonary hypertension has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension
• Pulmonary Hypertension

Drugs mentioned

• Bardoxolone Methyl (bardoxolone methyl)

Snippet

Sponsor: Biogen | Conditions: Pulmonary Arterial Hypertension, Pulmonary Hypertension | Phase 2 | Status: COMPLETED | Results posted: 2021-07-23